Reports
Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
Global Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market: By Infection Type: Hospital-Acquired ABSSSI, Community-Acquired ABSSSI; By Route of Administration; By Distribution Channel; Regional Analysis; Historical Market and Forecast (2017-2027); Competitive Landscape; Industry Events and Developments
Global Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market Outlook
The global acute bacterial skin and skin structure infections (ABSSSI) treatment market is expected to grow at a CAGR of about 7% in the forecast period of 2022-2027 to reach a value of around USD 14 billion by 2026.
-Treatment-Market.png)
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America Leads the Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market
Skin infections can be easily treated when the appropriate treatment methods are available and when the ailments are appropriately diagnosed. Like other developed countries, North America has a robust healthcare system with an overall high reach across the continent. This, coupled with the increasing prevalence of skin infections, has been a major factor for the rise in the market for treatments for ABSSSI. Similarly, in the Asia Pacific regions, the rising population, greater awareness, and improving healthcare systems are contributing to the rise in the demand for such treatments. These factors are expected to create conducive conditions for the market for ABSSSI treatments.
Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment: Market Segmentation
ABSSSI are defined as skin infections with a lesion size of more than 75 cm2. These may be mild or severe infections in the form of carbuncles, post-surgical wound infections, and traumatic wound infections. Commonly, these are caused by pathogens like streptococcus pyogenes and Staphylococcus aureus. The drugs used on them are dependent on the type of pathogen which may have infected the skin. Occasionally, surgical methods may also be employed in addition to oral administration of drugs.
-Treatment-Market-by-infection-type.png)
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The acute bacterial skin and skin structure infections (ABSSSI) treatment industry can be segmented by infection type:
- Hospital-acquired ABSSSI
- Community-acquired ABSSSI
- Others
It may be differentiated on the basis of route of administration:
- Oral
- Parenteral
The industry may be classified on the basis of distribution channel:
- Hospital Pharmacy
- Retail Pharmacy
- Online
- Others
The regional markets for acute bacterial skin and skin structure infections (ABSSSI) treatment can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
-Treatment-Market-by-region.png)
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Research and Development into Pharmaceutics Gives Impetus to ABSSSI Treatment market
The growth of the market is being driven by rising skin infections triggered by the growing pollution, along with other factors. Similar to other pathogens, skin-infection-causing bacteria also evolve to give rise to antibiotic-resistant variants with similar potency for causing infections, as well as other newer strains causing different infections. As such, there is a consistent research to roll out newer and more effective treatments. Despite issues like strict government regulations and expirations of patents, increasing penetration of healthcare services across the world, especially in Asia Pacific, and Middle East and Africa, is expected to push upwards the demand for ABSSSI treatments across the globe.
Key Industry Players in the Global Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market
The report gives a detailed analysis of the following key players in the global acute bacterial skin and skin structure infections (ABSSSI) treatment market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- Debiopharm International SA
- Melinta Therapeutics, Inc.
- Paratek Pharmaceuticals, Inc.
- GlaxoSmithKline plc
- Others
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2020 |
| Historical Period | 2017-2021 |
| Forecast Period | 2022-2027 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Infection Type, Route of Administration, Distribution Channel, Region |
| Breakup by Infection Type | Hospital-Acquired ABSSSI, Community-Acquired ABSSSI, Others |
| Breakup by Route of Administration | Oral, Parenteral |
| Breakup by Distribution Channel | Hospital Pharmacy, Retail Pharmacy, Online, Others |
| Breakup by Region | North America, Latin America, Europe, Middle East and Africa, Asia Pacific |
| Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Debiopharm International SA, Melinta Therapeutics, Inc., Paratek Pharmaceuticals, Inc., GlaxoSmithKline plc, Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market Analysis
8.1 Key Industry Highlights
8.2 Global Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Historical Market (2017-2021)
8.3 Global Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market Forecast (2022-2027)
8.4 Global Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market by Infection Type
8.4.1 Hospital-Acquired ABSSSI
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2017-2021)
8.4.1.3 Forecast Trend (2022-2027)
8.4.2 Community-Acquired ABSSSI
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2017-2021)
8.4.2.3 Forecast Trend (2022-2027)
8.4.3 Others
8.5 Global Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market by Route of Administration
8.5.1 Oral
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2017-2021)
8.5.1.3 Forecast Trend (2022-2027)
8.5.2 Parenteral
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2017-2021)
8.5.2.3 Forecast Trend (2022-2027)
8.6 Global Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market by Distribution Channel
8.6.1 Hospital Pharmacy
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2017-2021)
8.6.1.3 Forecast Trend (2022-2027)
8.6.2 Retail Pharmacy
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2017-2021)
8.6.2.3 Forecast Trend (2022-2027)
8.6.3 Online
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2017-2021)
8.6.3.3 Forecast Trend (2022-2027)
8.6.4 Others
8.7 Global Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market by Region
8.7.1 Market Share
8.7.1.1 North America
8.7.1.2 Europe
8.7.1.3 Asia Pacific
8.7.1.4 Latin America
8.7.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2017-2021)
9.1.2 Forecast Trend (2022-2027)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2017-2021)
9.2.2 Forecast Trend (2022-2027)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2017-2021)
9.3.2 Forecast Trend (2022-2027)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2017-2021)
9.4.2 Forecast Trend (2022-2027)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2017-2021)
9.5.2 Forecast Trend (2022-2027)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 Debiopharm International SA
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 Melinta Therapeutics, Inc.
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 Paratek Pharmaceuticals, Inc.
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 GlaxoSmithKline plc
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 Others
13 Industry Events and Developments
List of Key Figures and Tables
1. Global Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market: Key Industry Highlights, 2016 and 2026
2. Global Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Historical Market: Breakup by Infection Type (USD Billion), 2017-2021
3. Global Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market Forecast: Breakup by Infection Type (USD Billion), 2022-2027
4. Global Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Historical Market: Breakup by Route of Administration (USD Billion), 2017-2021
5. Global Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market Forecast: Breakup by Route of Administration (USD Billion), 2022-2027
6. Global Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Historical Market: Breakup by Distribution Channel (USD Billion), 2017-2021
7. Global Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market Forecast: Breakup by Distribution Channel (USD Billion), 2022-2027
8. Global Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Historical Market: Breakup by Region (USD Billion), 2017-2021
9. Global Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market Forecast: Breakup by Region (USD Billion), 2022-2027
10. North America Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
11. North America Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
12. Europe Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
13. Europe Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
14. Asia Pacific Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
15. Asia Pacific Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
16. Latin America Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
17. Latin America Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
18. Middle East and Africa Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
19. Middle East and Africa Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
20. Global Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market Structure
Key Questions Answered in the Report
The global acute bacterial skin and skin structure infections (ABSSSI) treatment market is projected to grow at a CAGR of 7% between 2022 and 2027.
The major drivers of the market include the rising population, greater awareness, increasing research and development into pharmaceuticals, and the growing number of ambulatory patients seeking treatment.
The rising skin infections triggered by the growing pollution and increasing penetration of healthcare services are the key industry trends propelling the market's growth.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The market can be segmented by infection type into hospital-acquired ABSSSI and community-acquired ABSSSI, among others.
Based on the route of administration, the industry is categorised into oral and parenteral.
The distribution channels include hospital pharmacy, retail pharmacy, and online, among others.
The major players in the industry are Debiopharm International SA, Melinta Therapeutics, Inc., Paratek Pharmaceuticals, Inc., and GlaxoSmithKline plc, among others.
Analyst Review
The global acute bacterial skin and skin structure infections (ABSSSI) treatment market was driven by the rising skin infections triggered by the growing pollution in the historical period. Aided by the rising population and increasing penetration of healthcare services, the market is expected to witness further growth in the forecast period of 2022-2027, growing at a CAGR of 7%.
EMR's meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. The market can be segmented by infection type into hospital-acquired ABSSSI and community-acquired ABSSSI, among others. Based on the route of administration, the industry is categorised into oral and parenteral. The distribution channels include hospital pharmacy, retail pharmacy, and online, among others. The major regional markets for acute bacterial skin and skin structure infections (ABSSSI) treatment are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The major players in the industry are Debiopharm International SA, Melinta Therapeutics, Inc., Paratek Pharmaceuticals, Inc., and GlaxoSmithKline plc, among others.
EMR's research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateFive User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
The global neurological disease treatment market was driven by the rapidly increasing prevalence and incidence of neurological disorders, such as multiple sclerosis, Parkinson's disease, and Alzheimer...
The global hepatic disease treatment market attained a value of nearly USD 21.97 billion, driven by the rise in the prevalence of liver diseases. Aided by the increasing alcohol consumption and growin...
The global autism spectrum disorder therapeutics market attained a value of about USD 3.33 billion in 2021, driven by the rising research and development projects fostered by the government and market...
The global glaucoma therapeutics market attained a value of USD 7.24 billion in 2021, driven by the rising prevalence of glaucoma worldwide. Aided by the favourable reimbursement policies and growing ...
The global central nervous system treatment market was driven by the increasing incidence of neurological disorders in the historical period. Aided by the launch of new prospective products and pipeli...
NEWSLETTER